-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 30, Tianyao issued an announcement stating that its subsidiary Tianjin Jinyao Pharmaceutical Co.
Methylprednisolone sodium succinate for injection is a glucocorticoid drugs, mainly for anti-inflammatory therapy, immunosuppressive therapy, the treatment of blood diseases and tumors, the treatment of shock and the like
Up to now, Jinyao Pharmaceutical has invested about 10 million yuan in research and development projects for the consistency evaluation of methylprednisolone sodium succinate for injection (40mg specifications), and has invested about R&D projects for all specifications of methylprednisolone sodium succinate for injection.
The original manufacturer of methylprednisolone sodium succinate for injection is Pfizer, the trade name is SOLU-MEDROL.